Cullinan Therapeutics (CGEM) Minority Interest (2020 - 2023)

Cullinan Therapeutics' Minority Interest history runs 4 years deep, the most recent figure standing at $192000.0 for Q4 2023.

• On a quarterly basis, Minority Interest changed N/A year-over-year to $192000.0 in Q4 2023; TTM through Dec 2023 was $192000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $192000.0, changed N/A from the prior year.
• Minority Interest rose to $192000.0 in Q4 2023 per CGEM's latest filing, from $80000.0 in the prior quarter.
• Across five years, Minority Interest topped out at $3.0 million in Q2 2021 and bottomed at $80000.0 in Q2 2022.
• The 4-year median for Minority Interest is $1.3 million (2020), against an average of $1.4 million.
• Across the five-year window, Minority Interest soared 135.7% in 2021 and plunged 97.33% in 2022, its largest moves.
• Year by year, Minority Interest stood at $1.3 million in 2020, then sank by 69.1% to $403000.0 in 2021, then sank by 80.15% to $80000.0 in 2022, then surged by 140.0% to $192000.0 in 2023.
• Per Business Quant, the three latest CGEM Minority Interest figures stand at $192000.0 (Q4 2023), $80000.0 (Q2 2022), and $768000.0 (Q1 2022).